Gencor to introduce new weight management ingredient at Expo West

Image | adobe.stock/Mnt

Gencor has announced that it will debut its new ingredient, Trpti, at Natural Products Expo West, taking place March 4-7, 2025, in Anaheim, California. Marketed at Trpti, oleoylethanolamide (OAE) is a fatty acid ethanolamide that supports weigh management and metabolic health. According to the company, OAE stimulates the release of GLP-1 through a G protein-coupled receptor-dependent mechanism (GPR119), helping to reduce food intake. Called a signaling molecule, it helps the breakdown of fat by activating peroxisome proliferator-activated receptor-alpha (PPAR-α). It is produced in the small intestine in response to food ingestion.

“We are thrilled to bring Trpti to market; it’s a first-of-its-kind ingredient with a unique mechanism of action, especially regarding its stimulation of GLP-1 through G protein-coupled receptors,” said Ramasamy Venkatesh, co-founder and managing director of Gencor, in a press release. “We are researching multiple doses to understand the potential dose-response effect; so far, our studies at a dosage of 300 mg per day have demonstrated significant success in supporting healthy weight management.”

Trpti features LipiSperse technology that preserves OAE as it reaches the gut, compared to traditional OAE supplements that are broken down by the enzyme FAAH. Formats for Trpti include dietary supplements, food and beverages.

Gencor will be at booth 3611 at the Expo.

The company also recently released results from the study, “Palmitoylethanolamide (Levagen+) for acute menstrual pain: a randomized, crossover, double-blind, placebo-controlled trial,” which found that Levagen+ was a safe and effective alternative for managing menstrual pain.